REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$8.69
+0.81%
Mkt Cap $452.17M
Analyst Ratings
Buy
10
Hold
1
Sell
0
Price Target (19 analysts)
$26.00
Range $12.00 – $45.00
Implied Upside
+199.2%
Consensus $26.00 vs current $8.69
NASDAQ·Healthcare·Biotechnology
$8.69
+0.81%
Mkt Cap $452.17M
Buy
10
Hold
1
Sell
0
Price Target (19 analysts)
$26.00
Range $12.00 – $45.00
+199.2%
Consensus $26.00 vs current $8.69